Pergam S A, Forsberg C W, Boeckh M J, Maynard C, Limaye A P, Wald A, Smith N L, Young B A
Department of Medicine, University of Washington, Seattle, Washington 98109, USA.
Transpl Infect Dis. 2011 Feb;13(1):15-23. doi: 10.1111/j.1399-3062.2010.00547.x.
Immunosuppressed patients are at increased risk for herpes zoster (HZ), but incidence in solid organ transplant (SOT) recipients has varied in multiple studies. To assess incidence of HZ, we examined patients who underwent SOT and received follow-up care within the large multicenter US Department of Veteran's Affairs healthcare system.
Incident cases of HZ were determined using ICD-9 coding from administrative databases. A multivariable Cox proportional hazards model, adjusted for a priori risk factors, was used to assess demographic factors associated with development of HZ.
Among the 1077 eligible SOT recipients, the cohort-specific incidence rate of HZ was 22.2 per 1000 patient-years (95% confidence interval [CI], 18.1-27.4). African Americans (37.6 per 1000 [95% CI, 25.0-56.6]) and heart transplants recipients (40.0 per 1000 [95% CI, 23.2-68.9]) had the highest incidence of HZ. Patients transplanted between 2005 and 2007 had the lowest incidence (15.3 per 1000 [95% CI, 8.2-28.3]). In a multivariable model, African Americans (hazard ratio [HR] 1.88; 95% CI: 1.12, 3.17) and older transplant recipients (HR 1.13; 95% CI: 1.01, 1.27 [per 5-year increment]) had increased relative hazards of HZ.
These data demonstrate that HZ is a common infectious complication following SOT. Future studies focused on HZ prevention are needed in this high-risk population.
免疫抑制患者发生带状疱疹(HZ)的风险增加,但在多个研究中,实体器官移植(SOT)受者的发病率有所不同。为评估HZ的发病率,我们在美国退伍军人事务部大型多中心医疗保健系统中检查了接受SOT并接受随访的患者。
使用行政数据库中的ICD-9编码确定HZ的发病病例。采用多变量Cox比例风险模型,并对先验风险因素进行调整,以评估与HZ发生相关的人口统计学因素。
在1077名符合条件的SOT受者中,HZ的队列特异性发病率为每1000患者年22.2例(95%置信区间[CI],18.1 - 27.4)。非裔美国人(每1000例中37.6例[95%CI,25.0 - 56.6])和心脏移植受者(每1000例中40.0例[95%CI,23.2 - 68.9])的HZ发病率最高。2005年至2007年期间接受移植的患者发病率最低(每1000例中15.3例[95%CI,8.2 - 28.3])。在多变量模型中,非裔美国人(风险比[HR]1.88;95%CI:1.12,3.17)和年龄较大的移植受者(HR 1.13;95%CI:1.01,1.27[每增加5岁])发生HZ的相对风险增加。
这些数据表明,HZ是SOT后常见的感染性并发症。需要针对这一高风险人群开展未来聚焦于HZ预防的研究。